Identification of a novel UMOD mutation (c.163G>A) in a Brazilian family with autosomal dominant tubulointerstitial kidney disease
Jazyk angličtina Země Brazílie Médium electronic
Typ dokumentu kazuistiky, časopisecké články
Grantová podpora
R21 DK106584
NIDDK NIH HHS - United States
PubMed
29513881
PubMed Central
PMC5912098
DOI
10.1590/1414-431x20176560
PII: S0100-879X2018000300616
Knihovny.cz E-zdroje
- MeSH
- biopsie MeSH
- genotyp MeSH
- lidé středního věku MeSH
- lidé MeSH
- mutace genetika MeSH
- polycystické ledviny autozomálně dominantní genetika patologie MeSH
- rodokmen MeSH
- uromodulin genetika MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
- Názvy látek
- UMOD protein, human MeSH Prohlížeč
- uromodulin MeSH
Autosomal dominant tubulointerstitial kidney disease (ADTKD) is characterized by autosomal dominant inheritance, progressive chronic kidney disease, and a bland urinary sediment. ADTKD is most commonly caused by mutations in the UMOD gene encoding uromodulin (ADTKD-UMOD). We herein report the first confirmed case of a multi-generational Brazilian family with ADTKD-UMOD, caused by a novel heterozygous mutation (c.163G>A, GGC→AGC, p.Gly55Ser) in the UMOD gene. Of 41 family members, 22 underwent genetic analysis, with 11 individuals found to have this mutation. Three affected individuals underwent hemodialysis, one peritoneal dialysis, and one patient received a kidney transplant from a family member later found to be genetically affected. Several younger individuals affected with the mutation were also identified. Clinical characteristics included a bland urinary sediment in all tested individuals and a kidney biopsy in one individual showing tubulointerstitial fibrosis. Unlike most other reported families with ADTKD-UMOD, neither gout nor hyperuricemia was found in affected individuals. In summary, we report a novel UMOD mutation in a Brazilian family with 11 affected members, and we discuss the importance of performing genetic testing in families with inherited kidney disease of unknown cause.
Zobrazit více v PubMed
Eckardt KU, Alper SL, Antignac C, Bleyer AJ, Chauveau D, Dahan K, et al. Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management - A KDIGO consensus report. Kidney Int. 2015;88:676–683. doi: 10.1038/ki.2015.28. PubMed DOI
Zivna M, Hulkova H, Matignon M, Hodanova K, Vylet'al P, Kalbacova M, et al. Dominant renin gene mutations associated with early-onset hyperuricemia, anemia, and chronic kidney failure. Am J Hum Genet. 2009;85:204–213. doi: 10.1016/j.ajhg.2009.07.010. PubMed DOI PMC
Kirby A, Gnirke A, Jaffe DB, Baresova V, Pochet N, Blumenstiel B, et al. Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing. Nat Genet. 2013;45:299–303. doi: 10.1038/ng.2543. PubMed DOI PMC
Verhave JC, Bech AP, Wetzels JF, Nijenhuis T. Hepatocyte nuclear factor 1beta-associated kidney disease: more than renal cysts and diabetes. J Am Soc Nephrol. 2016;27:345–353. doi: 10.1681/ASN.2015050544. PubMed DOI PMC
Bolar NA, Golzio C, Zivna M, Hayot G, Van Hemelrijk C, Schepers D, et al. Heterozygous loss-of-function SEC61A1 Mutations cause autosomal-dominant tubulo-interstitial and glomerulocystic kidney disease with anemia. Am J Hum Genet. 2016;99:174–187. doi: 10.1016/j.ajhg.2016.05.028. PubMed DOI PMC
Venkat-Raman G, Gast C, Marinaki A, Fairbanks L. From juvenile hyperuricaemia to dysfunctional uromodulin: an ongoing metamorphosis. Pediatr Nephrol. 2016;31:2035–2042. doi: 10.1007/s00467-015-3308-y. PubMed DOI
Bleyer AJ, Kmoch S. Autosomal dominant tubulointerstitial kidney disease: of names and genes. Kidney Int. 2014;86:459–461. doi: 10.1038/ki.2014.125. PubMed DOI
Pook MA, Jeremiah S, Scheinman SJ, Povey S, Thakker RV. Localization of the Tamm-Horsfall glycoprotein (uromodulin) gene to chromosome 16p12.3-16p13.11. Ann Hum Genet. 1993;57((Part 4)):285–290. doi: 10.1111/j.1469-1809.1993.tb00902.x. PubMed DOI
Bleyer AJ, Trachtman H, Sandhu J, Gorry MC, Hart TC. Renal manifestations of a mutation in the uromodulin (Tamm Horsfall protein) gene. Am J Kidney Dis. 2003;42:E20–E26. doi: 10.1016/S0272-6386(03)00670-X. PubMed DOI
Mutig K, Kahl T, Saritas T, Godes M, Persson P, Bates J, et al. Activation of the bumetanide-sensitive Na+,K+,2Cl- cotransporter (NKCC2) is facilitated by Tamm-Horsfall protein in a chloride-sensitive manner. J Biol Chem. 2011;286:30200–30210. doi: 10.1074/jbc.M111.222968. PubMed DOI PMC
Rampoldi L, Caridi G, Santon D, Boaretto F, Bernascone I, Lamorte G, et al. Allelism of MCKD, FJHN and GCKD caused by impairment of uromodulin export dynamics. Hum Mol Genet. 2003;12:3369–3384. doi: 10.1093/hmg/ddg353. PubMed DOI
Smith GD, Robinson C, Stewart AP, Edwards EL, Karet HI, Norden AG, et al. Characterization of a recurrent in-frame UMOD indel mutation causing late-onset autosomal dominant end-stage renal failure. Clin J Am Soc Nephrol. 2011;6:2766–2774. doi: 10.2215/CJN.06820711. PubMed DOI PMC
Vyletal P, Bleyer AJ, Kmoch S. Uromodulin biology and pathophysiology - an update. Kidney Blood Press Res. 2010;33:456–475. doi: 10.1159/000321013. PubMed DOI
Bleyer AJ, Woodard AS, Shihabi Z, Sandhu J, Zhu H, Satko SG, et al. Clinical characterization of a family with a mutation in the uromodulin (Tamm-Horsfall glycoprotein) gene. Kidney Int. 2003;64:36–42. doi: 10.1046/j.1523-1755.2003.00081.x. PubMed DOI
Blumenstiel B, DeFelice M, Birsoy O, Bleyer AJ, Kmoch S, Carter TA, et al. Development and validation of a mass spectrometry-based assay for the molecular diagnosis of Mucin-1 kidney disease. J Mol Diagn. 2016;18:566–571. doi: 10.1016/j.jmoldx.2016.03.003. PubMed DOI
Bollee G, Dahan K, Flamant M, Moriniere V, Pawtowski A, Heidet L, et al. Phenotype and outcome in hereditary tubulointerstitial nephritis secondary to UMOD mutations. Clin J Am Soc Nephrol. 2011;6:2429–2438. doi: 10.2215/CJN.01220211. PubMed DOI PMC
Lhotta K, Gehringer A, Jennings P, Kronenberg F, Brezinka C, Andersone I, et al. Familial juvenile hyperuricemic nephropathy: report on a new mutation and a pregnancy. Clin Nephrol. 2009;71:80–83. doi: 10.5414/CNP71080. PubMed DOI
Piret SE, Danoy P, Dahan K, Reed AA, Pryce K, Wong W, et al. Genome-wide study of familial juvenile hyperuricaemic (gouty) nephropathy (FJHN) indicates a new locus, FJHN3, linked to chromosome 2p22.1-p21. Hum Genet. 2011;129:51–58. doi: 10.1007/s00439-010-0897-1. PubMed DOI
Rampoldi L, Scolari F, Amoroso A, Ghiggeri G, Devuyst O. The rediscovery of uromodulin (Tamm-Horsfall protein): from tubulointerstitial nephropathy to chronic kidney disease. Kidney Int. 2011;80:338–347. doi: 10.1038/ki.2011.134. PubMed DOI
Hart TC, Gorry MC, Hart PS, Woodard AS, Shihabi Z, Sandhu J, et al. Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J Med Genet. 2002;39:882–892. doi: 10.1136/jmg.39.12.882. PubMed DOI PMC
Dahan K, Devuyst O, Smaers M, Vertommen D, Loute G, Poux JM, et al. A cluster of mutations in the UMOD gene causes familial juvenile hyperuricemic nephropathy with abnormal expression of uromodulin. J Am Soc Nephrol. 2003;14:2883–2893. doi: 10.1097/01.ASN.0000092147.83480.B5. PubMed DOI
Scolari F, Izzi C, Ghiggeri GM. Uromodulin: from monogenic to multifactorial diseases. Nephrol Dial Transplant. 2015;30:1250–1256. doi: 10.1093/ndt/gfu300. PubMed DOI
UMOD Mutations that Cause Uromodulin Kidney Disease Wake Forest School of Medicine. UKD Foudation; 2017. http://www.ukdcure.org/mutation_catalog Available at.
Moskowitz JL, Piret SE, Lhotta K, Kitzler TM, Tashman AP, Velez E, et al. Association between genotype and phenotype in uromodulin-associated kidney disease. Clin J Am Soc Nephrol. 2013;8:1349–1357. doi: 10.2215/CJN.11151012. PubMed DOI PMC
Bleyer AJ, Kidd K, Zivna M, Kmoch S. Autosomal dominant tubulointerstitial kidney disease. Adv Chronic Kidney Dis. 2017;24:86–93. doi: 10.1053/j.ackd.2016.11.012. PubMed DOI PMC
Raffler G, Zitt E, Sprenger-Mahr H, Nagel M, Lhotta K. Autosomal dominant tubulointerstitial kidney disease caused by uromodulin mutations: seek and you will find. Wien Klin Wochenschr. 2016;128:291–294. doi: 10.1007/s00508-015-0948-7. PubMed DOI
Lhotta K, Piret SE, Kramar R, Thakker RV, Sunder-Plassmann G, Kotanko P. Epidemiology of uromodulin-associated kidney disease - results from a nation-wide survey. Nephron Extra. 2012;2:147–158. doi: 10.1159/000339102. PubMed DOI PMC
Medeiros MM, Silva GB, Jr, Daher EF. Tophus gout and chronic kidney disease in a young female patient: report of familial juvenile hyperuricemic nephropathy in three generations of the same family. Rheumatol Int. 2012;32:3687–3690. doi: 10.1007/s00296-011-2106-5. PubMed DOI
Kuma A, Tamura M, Ishimatsu N, Miyamoto T, Serino R, Ishimori S, et al. A novel UMOD gene mutation associated with uromodulin-associated kidney disease in a young woman with moderate kidney dysfunction. Intern Med. 2015;54:631–635. doi: 10.2169/internalmedicine.54.3151. PubMed DOI
Lee MN, Jun JE, Kwon GY, Huh WS, Ki CS. A novel UMOD mutation (c.187T>C) in a Korean family with juvenile hyperuricemic nephropathy. Ann Lab Med. 2013;33:293–296. doi: 10.3343/alm.2013.33.4.293. PubMed DOI PMC
Nakayama M, Mori Y, Ota N, Ishida M, Shiotsu Y, Matsuoka E, et al. A Japanese family suffering from familial juvenile hyperuricemic nephropathy due to a rare mutation of the uromodulin gene. Case Rep Nephrol Urol. 2012;2:15–19. doi: 10.1159/000337343. PubMed DOI PMC